Introduction
The human hepatitis B virus (HBV) is one of the few human viruses associated with cancer development and is regarded as the major etiological factor of hepatocellular carcinoma in the world (Beasley, 1988) . Early cloning of the HBV genome (Fritsch et al., 1978) together with the limited genetic information carried by the virus (Galibert et al., 1979) have stimulated intensive molecular studies of the virus life cycle. Thus, our present knowledge of the replication mode of HBV is very detailed (Nassal and Schaller, 1996) , in sharp contrast with our still poor understanding of the mechanisms underlying HBV-associated carcinogenesis.
Two highly related viruses, the woodchuck hepatitis virus (WHV) and the ground squirrel hepatitis virus (GSHV) also cause liver cancer in their hosts (Buendia, 1992) , suggesting common mechanisms in hepadnavirus-associated carcinogenesis. However, an initially favored mechanism, namely insertional mutagenesis of host genes by integrated viral DNA, is now known to be a distinctive feature of WHV (Buendia, 1992) . Therefore, common elements in the pathway leading from chronic infection by mammalian hepatitis B viruses to tumor development have yet to be found. In this respect, it is striking that three mammalian hepadnaviruses share a regulatory gene termed X, whereas no counterpart of this gene is found in the related but non oncogenic duck hepatitis B virus.
The *17 kDa X-encoded protein (HBx or pX) has focused much attention in the past years and many dierent biological properties have been ascribed to the protein (Yen, 1996) . Thus, HBx has been reported to aect transcription, signal transduction, DNA repair, cell cycle control and apoptosis. Furthermore, HBx has been shown to be essential for productive infection in the woodchuck model (Chen et al., 1993; Zoulim et al., 1994) . So far however, genetic dissection of the pleiotropic eects ascribed to the protein as well as the identi®cation of the activity required in the virus life cycle have not been achieved. In addition, several of the reported HBx properties look contradictory. For instance, HBx was found by one group to counteract p53-induced apoptosis (Wang et al., 1995) whereas another group reported a p53-dependent proapoptotic eect of the viral protein (Chirillo et al., 1997) . Even the currently best documented HBx activity, namely transcriptional transactivation of a wide range of cellular and viral promoters (Rossner, 1992) , has not received a clear mechanistic explanation. Thus, in several studies, a direct eect on the transcription process has been proposed, based on physical and functional interactions of HBx with several components of the transcriptional machinery (Cheong et al., 1995; Haviv et al., 1996; Lin et al., 1997; Maguire et al., 1991; Qadri et al., 1995) , whereas in others, an indirect eect involving activation of signaling cascades has been documented (Benn and Schneider, 1994; Benn et al., 1996; Cross et al., 1993; Natoli et al., 1994) .
As to the possible HBx-cellular partners, many unrelated proteins have been proposed. Among known proteins, one may quote a proteasome subunit (Fischer et al., 1995; Huang et al., 1996) , the common subunit of RNA polymerases, RPB5 (Cheong et al., 1995) , the CREB transcription factor (Maguire et al., 1991) , the p53 tumor suppressor (Truant et al., 1995) and the UV-damaged DNA binding protein (UVDDB) (Lee et al., 1995; Sitterlin et al., 1997) .
Therefore, our present picture of the relationship that HBx may establish with the host cell has not clari®ed the role of the protein in the carcinogenic process and in the virus life cycle. Diculty in unraveling HBx functions might come in part, from the fact that many investigations were based on transient expression systems using strong expression vectors. In these systems, a subpopulation of cells is expressing HBx at a high level, a setting probably very dierent from that of chronic infection where only low production of the protein has been observed (Dandri et al., 1996) . A cellular model of constitutive HBx expression might therefore represent an alternative and valuable tool for a more natural study of HBx interaction with the host cell.
In this work, we performed stable transfections of two alleles of the X gene encoding wild type HBx and the M7 insertional mutant, found to in inactive in transactivation, in a transient expression system (Runkel et al., 1993) and de®cient in the binding to the cellular protein UVDDB (Sitterlin et al., 1997) . Constitutive expression of both types of protein was obtained in Chang (CCL-13) recipient cells. This allowed us to examine several aspects of the reported HBx-mediated activities in relationship to the transactivation activity of the protein. In this cellular model, expression of transactivation-active HBx potentiated the apoptotic response of the host cell whereas it did not result in detectable stimulation of the MAP kinases pathways nor did it interfere with the nucleotide excision repair process.
Results
Generation of stable cell lines expressing wild type or mutant HBx protein CCL-13 cells were co-transfected with pSV2-neo and a tenfold excess of pSVK3-HBx plasmid. In this plasmid, expression of wild type HBx protein fused to a Nterminal HA epitope is driven by a SV40 promoter. Empty pSVK3 was used in parallel in the same experimental conditions. G418-resistant colonies of similar size were obtained at a frequency of about eight colonies per 10 5 transfected cells in both transfection experiments. HBx protein of the expected size was detectable after immunoprecipitation in four out of six clones randomly selected from the pSVK3-HBx transfectants (data not shown). Taken together, these data suggest that in this expression system, HBx neither conferred an obvious growth selective advantage nor exhibited a marked toxicity. Using the same transfection procedure, we generated cell lines expressing a HBx mutant termed M7, which belongs to a panel of well-characterized Arg-Pro insertional HBx mutants generated by Runkel et al. (1993) . The M7 mutation, located at position 68 of the protein, was shown to destroy HBx-mediated transactivation in transient assays (Runkel et al., 1993) and to strongly decrease the binding of HBx to its host partner, UVDDB (Sitterlin et al., 1997) .
Noticeably, HBx detection required an immunoprecipitation step prior to immunoblotting, suggesting that the viral protein accumulated in rather low amounts, as in the case of chronic infection by hepadnaviruses (Dandri et al., 1996) . Analysis of HBx expression indicated that the highest and lowest levels of viral protein were produced by WT2 and WT3 clones respectively (Figure 1 and data not shown), both clones arising from the transfection with wild type X gene. Two clones, WT1 and M7-1 producing equivalent amounts of wild type and mutant HBx protein respectively (Figure 1 ), were selected for further functional analysis. The dierence in protein abundance between the cell lines was re¯ected at the mRNA level: PhosphorImager quanti®cation of the hybridization signals indicated that in WT2, the X transcript accumulated ®ve times more than in M7-1 and WT1 and 20 times more than in WT3 (Figure 1 ). (Upper) after electrophoresis, total RNA extracted from the indicated cell lines was transferred onto nylon membrane for Northern analysis. Shown are two exposures of the membrane hybridized with a probe encompassing HBV X ORF and an autoradiogram of the same membrane stripped and rehybridized with a 18 S rDNA probe, as RNA-loading control. Neo is a CCL-13-derived clone isolated from the co-transfection of pSV2-neo with empty pSVK3 vector. M7-1, WT1, WT2 and WT3 are CCL-13-derived clones expressing mutant or wild type HBx as described in the text. (Lower) following immunoprecipitation (IP) using a rabbit polyclonal anti-HBx antiserum, the indicated cell lysates were subjected to SDS ± PAGE and transferred onto nitrocellulose membrane for Western analysis (WB) with a mouse monoclonal anti-HA epitope antibody. The HBx speci®c band is indicated by an arrow: note that the M7 insertional mutant showed a slightly decreased mobility as compared to wild type protein. Rabbit IgG light chain present in the immunoprecipitates (IgL) was also revealed, due to cross-reactivity with the antimouse IgG secondary antibody Constitutive HBx-mediated transactivation in cell lines expressing wild type HBx
In order to examine the transactivation activity of the viral protein in the HBx + cell lines, we performed parallel transient transfection experiments using two luciferase reporter plasmids. In pSV2-luc, luciferase is driven by a SV40 enhancer-promoter known to be HBx-sensitive (Rossner, 1992) whereas in pE1B-TATA-luc, transcription from the E1b adenoviral gene TATA element is predicted to be only minimally aected by HBx. The ratio of the two luciferase reporter activities, once normalized for transfection eciency using a co-transfected b-galactosidase reporter, was determined for each cell line. Figure 2 illustrates the results of three independent representative experiments. M7-1, which expressed mutant HBx protein, did not show increased transcriptional activity of the HBx-sensitive reporter, when compared to CCL-13. In M7-1, the activity of the SV40 reporter element relative to that of the minimal TATA tox was even reproducibly below the level measured in control cells. In contrast, the activity of the HBx-sensitive reporter was signi®cantly higher in WT1 and WT3 than in the parent cells. However WT2, which produced the highest HBx level ( Figure  1 ), did not show this pro®le although RT ± PCR ampli®cation and subsequent sequencing indicated that the X ORF expressed in this clone was entirely wild type (data not shown). These observations led us to address whether up-regulation of the SV40 reporter observed in WT1 cells truly re¯ected HBx-mediated transactivation. To this aim, we derived new stable cell lines from both WT1 and parental cells by transfecting the hygromycin-selectable pDR2 vector, either empty or carrying an X gene in antisense orientation. Since pDR2 is maintained as an episome, a homogeneous cell population of stable transfectants is generated. Production of antisense X RNA in WT1 led to strongly reduced accumulation of the sense transcript (Figure 3a , upper; compare lanes 3 and 4) and HBx protein was no longer detectable in the cells (Figure 3a , lower; compare lanes 1 and 2 with lanes 3 and 4). Remarkably, upon expression of the antisense X gene, pSV2-luc expression remained unchanged in the parent cell line whereas returning to basal level in WT1 cells (Figure 3b ). We infer from these results that HBx is transactivation-competent in WT1 whereas in WT2, the protein is maintained in an inactive state, as to the stimulation of transcription. Therefore, regardless of the mechanisms underlying the WT2 phenotype, this clone provided an additional tool to investigate the potential correlation between transactivation and other activities of the viral protein.
Since phenotypic analysis of HBx M7 insertional mutation has been initially conducted using an AP1-driven reporter (Runkel et al., 1993) , we next investigated the behavior of dierent regulatory elements in both WT1 and M7-1 cells. One representative experiment is illustrated in Figure 4 . AP1 and NFKB binding sites as well as cAMP responsive (CRE) elements were all activated in WT1 cells whereas none of them responded to mutant HBx. Therefore, M7 mutation does not discriminate these HBx targets suggesting that the mutation disrupts a common step in HBx-mediated transactivation. Finally, it should be mentioned that cisactivation by HBV enhancer I region was not detectable in CCL-13 cells and that this element did not respond in trans to HBx expression in WT1 cells (data not shown).
Expression of active HBx and cell growth
Expression of active HBx did not confer a growth advantage to WT1 cells ( Figure 5 ). Instead, these cells showed a slightly decreased growth rate as compared to parental cells ( Figure 5a , b and c) and reached growth saturation at a lower density ( Figure  5d ). However, the assay used measured only the net growth rate and HBx was previously reported to stimulate MAP kinases cascades transducing mitogenic stimuli, i.e. the extracellular regulated kinase (ERK) pathway and stress stimuli, i.e. the stress activated protein kinase (SAPK) pathway (Benn and Schneider, 1994; Benn et al., 1996; Cross et al., 1993; Natoli et al., 1994) . We therefore investigated whether the activation pattern of these kinases was altered in the HBx + stable cell lines. To this aim, we performed immunoblotting analyses of cell extracts using antibodies speci®c for the phosphorylated active forms of either ERK1-ERK2 kinases ( Figure 6a ) or SEK1 kinase ( Figure 6b ). No signi®cant dierence in phosphorylated ERK content was observed between the cell lines, either after serum starvation (data not shown) or following serum stimulation (Figure 6a) . Similarly, the phosphorylated state of SEK1, the kinase that activates SAPK, did not dier between WT1 and the other cell lines, neither at the basal level nor following anisomycin induction (Figure 6b ). Figure 2 Transcriptional activity of SV40 enhancer-promoter in CCL13-derived stable cell lines. Transient co-transfections of the pTKb reporter with either pSV-luc or pE1B-TATA-luc were performed in parallel. The measured luciferase activities were normalized for transfection eciency using the b-galactosidase activities determined from the same cell extracts. The data represent the ratio of SV40 enhancer-promoter transcriptional activity to that of the minimal TATA box element, arbitrary brought back to one for the parent CCL-13 cells. Shown are the results of three independent experiments HBx and nucleotide excision repair of DNA Among other evidence, our previous ®nding that interaction of HBx with the cellular protein UVDDB correlates with the transactivation potential of HBx insertional mutants (Sitterlin et al., 1997) , suggests that UVDDB is involved in HBx-mediated transactivation. However, UVDDB was ®rst identi®ed on the basis of its speci®c binding to UV-damaged DNA (Abramic et al., 1991) . This activity was further found absent in several cell lines genetically de®cient in nucleotide excision repair (NER) (Keeney et al., 1992) , the cellular machinery that processes UV-induced DNA lesions. Although proof for a role of UVDDB in DNA repair is still missing, the possibility that HBx alters host cell NER process via interaction with UVDDB, deserved investigation.
Cell survival after UVC irradiation, was significantly lower for WT1 cells than for parental cells (Figure 7a ). However, UV irradiation not only causes DNA damage that requires proper repair, but also represents a cellular stress processed by a complex signaling cascade that delivers both death and survival signals (reviewed in Bender et al., 1997) . In order to more directly assess the possible interference of HBx with NER, we compared the abilities of parent and WT1 cells to repair an in vitro irradiated reporter plasmid (host cell reactivation assay). As shown in Figure 7b , the two cell lines showed an identical pro®le in this assay. Figure 4 M7 insertional mutation disrupts HBx-mediated transactivation of distinct upstream elements. The transcriptional activity of the indicated upstream elements relative to that of the minimal TATA box element were determined as described in the legend to Figure 2 Similarly, repair of exogenous DNA was unchanged in the M7-1 cell line expressing the mutant form of HBx (data not shown). Altogether, these observations indicate that HBx does not directly aect the NER machinery but might alter the cell response to environmental stresses.
HBx potentiates host cell apoptotic response
To further investigate the possibility that HBx might promote a cell death response to certain external stimuli, we compared the response of parent and WT1 cells to treatment by staurosporine or cycloheximide. These two unrelated agents are known to trigger the apoptotic pathway in many cell types. Staurosporine cytotoxicity was markedly enhanced in WT1 as compared to parental CCL-13 cells, with respect to both the dose eect (Figure 8a ) and the kinetics of the response (Figure 8b ). That enhanced cell death response of WT1 resulted from apoptosis was con®rmed in two ways: proteolytic activation of CPP32, a caspase involved in many apoptotic processes (Kroemer et al., 1995) , was detectable earlier and at a higher rate in WT1 than in parent cells (Figure 8c ; compare lanes 2 and 3 with lanes 5 and 6) and a higher proportion of WT1 cells showed chromatin condensation, a characteristic morphological change of apoptotic cells (Figure 8d ). This dierential eect of staurosporine was mediated by HBx since expression of antisense X RNA in WT1 cells restored a normal response (Figure 9a ). Interestingly, this eect was not observed in M7-1, WT2 and WT3 (Figure 9b ). Altogether, these data strongly suggest that a threshold of transactivation activity is required for the potentiation of apoptosis by HBx. Remarkably, cycloheximide showed a pattern of cytotoxicity similar to that of staurosporine ( Figure  9c and d) .
In addition to necrosis, regarded as a passive process and to the active apoptotic pathway, another form of cell death, known as mitotic cell death has been documented in several settings, including X-ray irradiated cells and HeLa cells overexpressing ras (Miranda et al., 1996) . Mitotic death also occurs in HeLa cells treated with low doses of the topoisomerase inhibitor etoposide (Lock et al., 1994) . In these cells, the prolonged G2 arrest in response to etoposide-induced DNA damage is eventually followed by a lethal mitotic catastrophe, characterized by multinucleation (Lock et al., 1994) . It should be recalled at this point that CCL-13, although also referred to as Chang liver cells, were shown to be HeLa derivatives (Lavappa et al., 1976) . As a con®rmation of their HeLa-derived origin, the two characteristic HeLa transcripts hybridizing with the Human Papilloma virus (HPV) E6-E7 regions were readily detectable in CCL-13 cells (data not shown). Therefore, CCL-13 like the original HeLa cells, lack the DNA-damage G1 checkpoint, due to functional p53 inactivation by the HPV E6 gene. This prompted us to examine whether HBx would aect etoposide-induced cell death of the recipient CCL-13 cells. No signi®cant dierence in the cytotoxic eect of the drug was observed between short term cultures of WT1 and control cells (data not shown) and clonogenic survival showed a very similar pro®le for WT1 and parent cells with an inferred LC50 of etoposide at about 2.3 mg/ml (Figure 10 ). These observations suggest that potentiation of the cell death response by active HBx is speci®c for the apoptotic pathway.
We next examined whether constitutive alteration of the cellular redox state or calcineurine activation might account for HBx-mediated stimulation of apoptosis because both parameters are known to in¯uence the point of no return in the apoptotic process (Kroemer et al., 1995) . The anti-oxidants NAC and PDTC showed adverse eects on cells, when used at high concentrations (data not shown). At the maximal concentrations tolerated by the cells, neither NAC nor PDTC was able to decrease the dierence between the two cells lines in the response to cycloheximide (Figure 11a) . Similarly, cyclosporin A, a potent inhibitor of calcineurin, failed to restore a normal death response in HBx-expressing cells ( Figure  11b ). Phosphorylation status of ERKs and SEK1 kinases in CCL-13-derived stable cell lines. (a) Cells were serum starved for 2 days in medium containing 0.1% serum. Cells were lysed after a 90 min stimulation period in 10% serum and the lysates subjected to Western analysis. Active ERK kinases (P-ERK1 and P-ERK2), indicated by arrows, were revealed by an antibody speci®c for the phosphorylated forms of the kinases. (b) Cells were grown in normal medium for 24 h after which medium was replaced by fresh medium without (7) or with 1 mg/ml anisomycin (+). Active SEK1 kinase (P-SEK1) was revealed by Western analysis using an antibody speci®c for the phosphorylated kinase. In (a and b) control of protein loading was achieved by simultaneous revelation of the 36 kDa heterotrimeric G protein Gb subunit, indicated by an arrow
Discussion
In this work, we generated and characterized cell lines stably expressing the hepatitis B virus X protein. To the best of our knowledge, it is the ®rst reported cellular model of constitutive HBx expression where the protein could be clearly revealed both at the structural level, by Western blot analysis and at the functional level, by its transactivation activity, allowing further functional analyses on well-de®ned grounds.
Our ®nding that in CCL13, a cell line where p53 is functionally inactivated by the HPV E6 gene product, HBx potentiated the apoptotic response to diverse stimuli has to be put together with other recent observations made in the same recipient cells. Thus, HBx was found to sensitize cells to TNF-mediated apoptosis in a transient expression system (Su and Schneider, 1997) and to directly trigger apoptosis, when overexpressed in an inducible expression system . On the other hand, a p53-dependent apoptotic eect of HBx that decreased clonogenic survival of non-transformed ®broblastic cells was documented (Chirillo et al., 1997) . In this respect, it should be emphasized that the low amount of p53 protein detected in CCL-13 (510% of that found in a cell line of wild type p53 status) did not dier among the cell lines used in this study, nor did it vary upon treatment with apoptotis-inducing agents (data not shown). Collectively, these data suggest that HBx exerts a proapoptotic eect at a threshold that might dier according to the p53 status of the host cell but that does not strictly require the activity of the tumor suppressor. Therefore, the often preferred choice of strong promoters to drive X expression might preclude the generation of cell lines stably expressing HBx, even in a p53-de®cient background. This may provide an explanation for the reported failure in obtaining such cellular models (Yen, 1996) . One should also keep in mind that in the context of viral infection, tight regulation of HBx levels and/or co-expression of other viral products may help to control the toxicity of HBx. Becker et al. (1998) reported that transient expression of HBx in HepG2 cells decreased host cell reactivation (HCR) of an irradiated reporter plasmid. In contrast, we found no eect of HBx in the recipient CCL-13 cells, using the same HCR assay. The p53 status of the recipient cells (wild type in HepG2 versus inactivated by HPV E6 protein in CCL-13) should again be considered to partly explain this discrepancy. Indeed, several studies have documented a speci®c alteration in the nucleotide excision repair (NER) pathway in cells lacking normal p53 activity as a result of mutations in the gene or of HPV E6 expression (Ford et al., 1998; Ford and Hanawalt, 1997; Smith et al., 1995) . Thus, these cells were defective in global NER, i.e. the repair of UV-induced lesions in non expressed regions of the genome and in the coding strand of transcriptionally active genes, but they retained normal NER of the transcribed strand of active genes (Ford et al., 1998; Ford and Hanawalt, 1997) . Therefore, one possibility would be that HBx impairs global NER via functional interaction with p53, a phenomenon that might be masked in the p53-de®cient cells used in our study. Alternatively, since repair intermediates occurring during NER are sucient to mobilize p53 activity (Jayaraman and , the reported HBx-mediated HCR decrease in HepG2 cells (Becker et al., 1998) might have not re¯ected defective NER, but rather increased cell commitment to apoptosis via synergy between activated wild type p53 and HBx. Noticeably, the WT1 cell line expressing transactivation-active HBx did not show an increased growth rate, as compared to the parental cells. This ®nding, in agreement with another report , is in contradiction with two other studies reporting a higher proliferation rate associated with HBx expression in a mutant p53 genetic background (Chirillo et al., 1997; Oguey et al., 1996) . We note that in the two latter studies, the level of endogenous HBx transactivation activity was not documented. Therefore, among other possibilities, the level of transactivation activity might determine whether HBx confers a proliferative advantage to the host cell. In certain experimental systems, the cell fate, namely proliferation or differentiation versus growth arrest or cell death, has been shown to be determined by the balance between two MAP kinase signaling cascades leading to the activation of ERK kinases and SAPK kinase, respectively (Xia et al., 1995) . However SEK kinase, which controls SAPK activation, as well as ERK kinases showed comparable phosphorylation patterns between the cell lines, whatever the transactivation status of HBx. These results are in discrepancy with the report by another group of HBx-mediated activation of both kinase cascades in CCL-13 cells (Benn et al., 1996) . We cannot rule out that the powerful transient expression system used by these authors, namely recombinant adenovirus, helped to reveal a phenomenon that escaped detection in our constitutive expression system.
The M7-1 cell line expressing a mutant version of HBx, which was unable to stimulate the transcription through several known HBx target sites, did not show Figure 9 Sensitivity pro®le of CCL-13-derived cell lines to apoptosis-inducing agents. Eect of antisense X RNA expression on WT1 response to staurosporine (a) and cycloheximide (c) and comparison of cell lines expressing transactivation-active or -inactive HBx for the cytotoxic eects of staurosporine (b) and cycloheximide (d). In b and d, cells were treated for 40 h with 20 nM staurosporine and 5 mg/ml cycloheximide respectively. The percentage of dead cells was determined as described in the legend to Figure 8b enhanced response to apoptotic stimuli. These observations indicate that transactivation and stimulation of the apoptotic pathway are linked activities. In this respect, the unexpected phenotype of the WT2 cell line expressing a high level of protein of wild type status but inactive in transactivation, deserves further comments. One hypothesis would be that absence of transactivation activity in this cell line resulted from a squelching phenomenon due to excess HBx amounts (Faktor and Shaul, 1990 ). However, we favor an alternative view in which, impaired HBx-mediated transactivation resulted from a genetic or an epigenetic change, that was selected in the initial WT2 transfectant. In any case, since susceptibility to apoptosis is not increased in WT2, the proapoptotic activity of HBx must lie downstream of its transactivation activity in a pathway likely involving dierent host proteins.
In a recent unifying view of the apoptotic process, all signaling cascades converge toward a critical event, i.e. the permeability transition (PT) of the mitochodrion (Kroemer et al., 1995) . In this view, HBxmediated increase of PT probability might account for the ability of the viral protein to synergize with many dierent apoptotic stimuli, staurosporine and cycloheximide (this study), p53 (Chirillo et al., 1997) and TNF (Su and Schneider, 1997) . Among parameters directly favoring PT, are the reactive oxygen species (ROS) and the calmodulin-dependent phosphatase calcineurin (Kroemer et al., 1995) . However, the enzymes involved in ROS production and calcineurin are unlikely to Figure 10 Expression of active HBx does not potentiate etoposide cytotoxicity in CCL-13 cells. Cells were plated at various densities and exposed to etoposide for 4 h. After drug removal, cells were grown for 10 days in normal medium and mean colony survival was estimated from triplicates plates. Results are expressed as a percentage of colony-forming eciency of non-treated cells Figure 11 HBx proapoptotic eect is resistant to anti-oxidants and to cyclosporin A. (a) Cells were incubated for 40 h with 5 mg/ ml cycloheximide, either alone or in co-treatment with 12.5 mM NAC or 20 mM PDTC. (b) Cells were pre-incubated 8 h with the indicated concentrations of cyclosporin A after which cycloheximide (5 mg/ml) was added to the medium for 40 h. The percentage of dead cells was determined as described in the legend to Figure 8b represent downstream HBx targets since anti-oxidants and cyclosporin A failed to restore a normal apoptotic response to HBx-expressing cells.
Apoptosis may also be the outcome of an abnormal cell cycle progression (Kroemer et al., 1995) . This possibility was not directly addressed in this work. However, it is worthwhile mentioning that HeLa cells were shown to be much more susceptible to staurosporine-induced as well as to TNF-induced apoptosis, when arrested in the S phase of the cell cycle (Meikrantz et al., 1994) . Remarkably, HBx sensitized CCL-13 to both agents (this study and Su and Schneider, 1997) , raising the possibility that HBx aects S phase progression.
In conclusion, at the level of transactivation activity where HBx exerted no detectable in¯uence on the MAP kinase pathways or on NER machinery, a speci®c increase in host cell susceptibility to apoptosis was underscored. Moreover, we provide evidence that potentiation by HBx of the apoptotic response is not only linked to but lies downstream of its transactivation activity. This proapoptotic eect might contribute to HBV-associated oncogenesis by exerting a selective pressure, that favors the emergence of mutated cells. In this respect, the WT2 cells described here might well be an illustration of this phenomenon. Since the production of HBV virions does not rely on host cell lysis, the biological signi®cance in the virus life cycle of a virusborne proapoptotic activity is less perceptible: which HBx viral function would then warrant the price of a negative side-eect on host cell survival? Comparison of the mammalian hepatitis viruses with their duck counterpart may give a clue: the former not only contain a X gene absent in the latter but also present a large gap in their positive genomic DNA strand, in contrast to the near complete double stranded genome found in DHBV virions (Mason et al., 1981) . As a speculation, ecient gap-®lling of the viral genome might depend on HBx-mediated recruitment of cellular activities involved in DNA synthesis, which are normally induced in the S phase of the cell cycle. The unscheduled recruitment of such activities for the bene®t of the virus would be at the expense of a higher host cell propensity to undergo apoptotic death.
Materials and methods

Cell lines and tissue culture
Chang liver cells, registered as CCL-13 in the American Tissue Type Collection were shown to be derived from the HeLa cervical carcinoma cells (this work and Lavappa et al., 1976) . Cells were grown at 378C in Dulbecco-modi®ed Eagle medium supplemented with 10% fetal calf serum, 2 mM glutamine and antibiotics (100 units/ml penicillin and 100 mg/ml streptomycin), in a 5% CO 2 -supplemented atmosphere.
Reagents
Etoposide and staurosporine (Clontech) were dissolved in DMSO as 100 mM and 1 mM stock solutions respectively. Anisomycin (Sigma) was prepared as a 20 mg/ml stock solution in methanol. Cyclosporin A (Biomol) was prepared as a 0.2 mM stock in ethanol. At the dilutions used, the organic solvents did not aect cell viability nor cell growth. Cycloheximide, N-acetyl cystein (NAC) and pyrrolidinedithiocarbamate (PDTC) were obtained from Sigma. Hoechst dye (Sigma) and Trypan blue (Gibco ± BRL) were used at a ®nal concentration of 2 mg/ml and 0.2% respectively. A tenfold diluted Giemsa solution (Merck) was used to stain cell colonies. G418 and hygromycin were purchased from Gibco ± BRL and Boehringer.
Plasmids
HBx expression plasmids were constructed as follows: wild type and M7 insertional mutant X genes (ayw subtype) fused to a 5' HA epitope sequence were retrieved by EcoRI ± SalI digestion from the previously described pAS2-HBx and pAS2-HBxM7 yeast vectors (Sitterlin et al., 1997) and subcloned into pSVK3 expression vector (Pharmacia). Antisense X expression plasmid (pDR2-antisense X) was created by ligating the BglII insert (HA-X gene) from the yeast pACT2-HBx vector (Sitterlin et al., 1997) into the BamHI site of pDR2 episomic vector (Clontech). pE1B-TATA-luc was created by ligation of the annealed oligonucleotides 5'-TCGAGAGGGTATATAATGA-3': 5'-GATCTCATTATATACCCTC-3' into XhoI ± BglII digested pGL3-Basic vector (Promega). In the resulting plasmid, the luciferase reporter is expressed from the minimal TATA box element of E1B adenoviral gene. pSV2-neo (Clontech) carries a neomycine resistance gene used as a selective marker. pTKb expression vector (Clontech) carries a b-galactosidase gene used for transfection eciency normalization. pSV2-luc encoding a luciferase reporter gene driven by SV40 early region promoter-enhancer has been described (de Wet et al., 1987) . Luciferase reporters controlled by three AP1 binding sites (pAP1-CONA-luc) and 6 NFKB binding sites (p3E-CONA-luc) respectively were kindly provided by N IsraeÈ l. The luciferase reporter controlled by cAMP responsive elements (pGL3-CRE-luc) was a kind gift of M Levrero.
Stable transfections
Transfection experiments were carried out by the classical calcium phosphate procedure. For the generation of CCL13-derived cell lines expressing HBV X gene, 1.5610 6 cells in 10-cm-diameter dishes were incubated 18 h with 22 mg DNA precipitate containing pSVK3 construct and pSV2-neo selection plasmid in the 10 : 1 ratio. After washing, cells were grown for 2 days in normal medium. Cells were then harvested and the cell suspension was plated at three densities (2610 6 , 1610 6 and 5610 5 cells per 10-cm dish) in selective medium containing 1 mg/ml G418 (Gibco). Selective medium was changed once a week. After 3 weeks, isolated G418-resistant colonies were harvested using cloning cylinders and expanded in selective medium. The cell lines carrying the episomic pDR2 constructs were generated in the same way, except that selection was carried out in medium containing 200 mg/ml hygromycin and that all the hygromycin-resistant colonies from the transfection dish were pooled for further expansion.
Transient transfections
The day before transfection, cells were seeded at about 1610 6 cells per 6-cm-diameter dish. In order to minimize variation in transfection eciency, a single calcium phosphate DNA precipitate was prepared and split onto the dierent cell lines to be transfected. Cells were exposed to the DNA precipitate for 18 h and 40 h post-transfection, luciferase and bgalactosidase enzymatic activities were measured as previously described (Fourel et al., 1992) . The reporter plasmids were used at the following amounts per transfection: pTKb, 2 mg; pE1B-TATA-luc, 3 mg; pSV2-luc, 0.025 ± 0.1 mg; pAP1-CONA-luc, 0.5 mg; p3E-CONA-luc, 0.5 mg; pGL3-CRE-luc, 0.5 mg. DNA from pBluescript (Stratagene) was used as carrier to adjust the total DNA amount to 6 mg per transfection. In the host cell reactivation assay, pSV2-luc DNA was irradiated prior to transfection at increasing UV-C doses (mainly 254 nm), using a¯uence rate of 7.6 J/m 2 /s.
Northern blot analysis
Total RNA was extracted using the RNA PLUS reagent (Bioprobe Systems). After electrophoresis in formaldehydecontaining agarose gel, RNA (30 mg/lane) was transferred onto Hybond-N + membrane (Amersham) and hybridized with 32 P-labeled DNA probes synthesized by the randompriming method. The X probe was generated by PCR amplication of the X ORF from a cloned HBV ayw genome. A 18 S rDNA probe (Valbiotech) was used for RNA-loading control.
Immunoprecipitation of HBx
Approximately 10 7 cells were washed twice in phosphate buered saline (PBS) and incubated for 30 min at 48C in 1 ml lysis buer (50 mM Tris.Cl pH 8, 150 mM NaCl, 1% NP40, 0.02% NaN 3 ), containing protease inhibitors. Cells were then scraped o the plates and the lysates clari®ed by centrifugation at 15 000 g for 15 min at 48C. Cell extracts (approximately 1 mg of protein) were incubated with 5 ml of rabbit polyclonal anti-HBx antiserum (a generous gift of A Kay) for 2 h at 48C under gentle agitation. Protein Asepharose beads (Pharmacia), previously equilibrated in lysis buer were then added for a 18 h incubation at 48C. Beads were washed six times in lysis buer, twice in 10 mM Tris.Cl pH 7.5; 0.1% Triton X-100 and resuspended in sample buer (60 mM Tris.Cl pH 6.8; 2% SDS; 100 mM DTT; 0.1% Bromophenol Blue; 10% glycerol). Immunoprecipitates were eluted from the beads by incubation at 958C for 5 min and subjected to SDS ± PAGE in a 15% gel.
Western blot analysis
For the detection of CPP32 caspase, cellular proteins were extracted in hypotonic buer, as described (Miossec et al., 1997) . For the detection of phosphorylated ERK1 ± ERK2 and SEK1 kinases, cells were washed in PBS and lysed directly on the dish, in sample buer. After SDS ± PAGE, proteins were transferred onto Hybond-C extra membranes (Amersham) using a semi-dry transfer apparatus (Biorad). Proteins were revealed by chemiluminescence using the Western-star detection kit (Tropix) according to supplier's instructions. Monoclonal anti-HA antibody (12CA5), obtained as raw ascites was used at 1 : 10 000 dilution. Monoclonal anti-CPP32 antibody (Immunotech) was used at a 1 : 20 dilution. Polyclonal anti-phosphorylated kinases antibodies (Biolabs) and anti-Gb subunit of heterotrimeric G proteins (Santa Cruz) were used at 1 : 1000 and 1 : 10 000 dilution, respectively. Serial dilution experiments of cell extracts indicated that a twofold dierence in the amount of phosphorylated kinases was detectable in the assay (data not shown).
Cell survival after UV-C irradiation
The assay was performed essentially as described (Weeda et al., 1997) . Cells were washed in PBS and were irradiated at various UV-C doses using a¯uence rate of 0.25 J/m 2 /s. Cells were then harvested and plated for a colony-forming assay, at densities varying from 10 2 to 4610 3 cells per 10-cm dish. After 15 days, the cells were ®xed in 100% ethanol and stained with Giemsa. The number of surviving colonies was counted in triplicate dishes.
WST-1 assay
Cells were seeded in 96-well plates in 100 ml medium per well. Ten microliters of WST-1 reagent (Boehringer) were added per well. Production of formazan by viable cells was monitored by recording the optical densities at 450 nm of quadruplicate wells, at dierent time points after incubation at 378C; only the values in the linear range of the reaction were selected for the calculation of relative growth rates or cell viabilities.
Clonogenic survival after etoposide treatment
Cells were plated at densities varying from 0.25610 3 to 5610 3 cells per 10-cm dish. After exposure to various etoposide concentrations during 4 h, cells were washed extensively and grown in normal medium for 10 days. The surviving colonies were stained with Giemsa and counted in triplicate plates.
